Case Studies
Druggability Technologies Case Study
Druggability Technologies (DRGT) was developing DRGT-46 as a novel therapy for pain. Gabor Heltovics, the former CEO of DRGT, explains how we enabled the rapid development, clinical assessment and commercial readiness of its drug product using integrated services across sites in the UK and the US.